Stock listing
Biorestorative Therapies, Inc.
- Ticker
- Lang & Schwarz: A3C9XF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Biorestorative Therapies, Inc.
Biorestorative Therapies, Inc. (BRTX) is a public company based in the United States, focused on developing innovative therapies for various medical conditions. BRTX is committed to improving patient outcomes through its specialized therapeutic solutions.
Latest news from Biorestorative Therapies, Inc.
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Sep 8, 2026
BioRestorative Therapies Announces Reverse Stock Split
Sep 2, 2026
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
Jun 25, 2026
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
Jun 18, 2026